Chat with us, powered by LiveChat

Cord Blood Safety Study

POSTED ON IN Latest News BY Chris Centeno

Congrats to Beike and Medistem for a well done safety study on expanded cord blood treatments in China for neurological disorders. Again, compared to the safety profile of common sledgehammer immune supressant drugs for conditions like Multiple Sclerosis., this therapy seems to be much safer.  While a bigger dataset followed for longer periods would be nice, this paper seems to support the safety profile already published by our group and others showing that cell based therapy complications are generally less than the more traditional therapies they help replace.


    comments for this post are closed

    About the Author

    Chris Centeno

    Christopher J. Centeno, M.D. is an international expert and specialist in regenerative medicine and the clinical use of mesenchymal stem cells in orthopedics. He is board certified in physical medicine as well as rehabilitation and in pain management through The American Board of Physical Medicine and Rehabilitation.…

    View Profile

    Search Blog